T-2 toxin impairs murine immune response to respiratory reovirus and exacerbates viral bronchiolitis

Toxicol Appl Pharmacol. 2006 Nov 15;217(1):76-85. doi: 10.1016/j.taap.2006.08.007. Epub 2006 Aug 12.

Abstract

Exposure to immunosuppressive environmental contaminants is a possible contributing factor to increased occurrence of viral respiratory diseases. The objective of this study was to test the hypothesis that the trichothecene mycotoxin T-2 toxin (T-2), a frequent food contaminant, alters host resistance to lung infection by reovirus, a model respiratory virus. Balb/c mice (4 week old) were treated intraperitoneally with T-2 toxin (1.75 mg/kg bw) or saline vehicle and then intranasally instilled 2 h later with 10(7) plaque forming unit (PFU) of reovirus, strain Lang (T1/L) or saline vehicle. At 10 days post-instillation (PI), both virus plaque-forming responses and reovirus L2 gene expression were 10-fold higher in lungs of T-2-treated mice compared to controls. No-effect and lowest-effect levels for T-2-induced suppression of reovirus clearance were 20 and 200 microg/kg bw, respectively. Respiratory reovirus infection resulted in a mild bronchiolitis with minimal alveolitis, which was markedly exacerbated by T-2 pretreatment. Reovirus exposure induced marked increases in total cells, neutrophils and lymphocytes at 3 and 7 days PI in bronchial alveolar lavage fluid (BALF) whereas macrophages were increased only at 7 days PI. Although prior T-2 exposure attenuated total cell and macrophage counts in BALF of control and infected mice at 3 days PI, the toxin potentiated total cell, macrophage, neutrophil and lymphocyte counts in infected mice at 7 days PI. At 3 days PI, T-2 suppressed reovirus-induced IFN-gamma elevation in BALF, but enhanced production of IL-6 and MCP-1. T-2 pretreatment also suppressed reovirus-specific mucosal IgA responses in lung and enteric tract, but potentiated serum IgA and IgG responses. Taken together, T-2 increased lung viral burden, bronchopneumonia and pulmonary cellular infiltration in reovirus-infected mice. These effects might be attributable to reduced alveolar macrophage levels as well as modulated cytokine and mucosal Ig responses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchiolitis, Viral / immunology*
  • Bronchiolitis, Viral / pathology
  • Bronchoalveolar Lavage Fluid / immunology
  • Bronchoalveolar Lavage Fluid / virology
  • Chemokine CCL2 / analysis
  • Chemotaxis, Leukocyte / drug effects
  • Cytokines / analysis*
  • Cytokines / biosynthesis
  • Dose-Response Relationship, Drug
  • Female
  • Immunoglobulin A / blood
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / toxicity*
  • Interferon-gamma / analysis
  • Interleukin-10 / analysis
  • Interleukin-6 / analysis
  • Lung / drug effects*
  • Lung / immunology
  • Lung / pathology
  • Lung / virology*
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Lymphocytes / virology
  • Mice
  • Mice, Inbred BALB C
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Neutrophils / virology
  • Orthoreovirus, Mammalian / immunology*
  • Reoviridae Infections / immunology*
  • Reoviridae Infections / pathology
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / immunology
  • Respiratory Mucosa / virology
  • T-2 Toxin / toxicity*
  • Tumor Necrosis Factor-alpha / analysis
  • Viral Load

Substances

  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Cytokines
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interferon-gamma
  • T-2 Toxin